Suppr超能文献

[己巴比妥代谢的新方面:立体选择性代谢、通过谷胱甘肽结合的新代谢途径以及 3-羟基己巴比妥脱氢酶]

[New aspects of hexobarbital metabolism: stereoselective metabolism, new metabolic pathway via GSH conjugation, and 3-hydroxyhexobarbital dehydrogenases].

作者信息

Takenoshita Reiko, Toki Satoshi

机构信息

Faculty of Pharmaceutical Sciences, Fukuoka University, fukuoka 814-0180, Japan.

出版信息

Yakugaku Zasshi. 2004 Dec;124(12):857-71. doi: 10.1248/yakushi.124.857.

Abstract

Hexobarbital, a short-acting hypnotic, is metabolized to 3'-hydroxyhexobarbital by cytochrome P450, and then to 3'-oxohexobarbital by liver cytosolic dehydrogenase. New methods of separation for hexobarbital and its metabolites by TLC have been developed and applied to study the metabolism of hexobarbital enantiomers and stereoselective metabolism of hexobarbital. (+)-Hexobarbital preferentially was transformed into beta-3'-hydroxyhexobarbital and the (-)-enantiomer preferentially transformed into alpha-3'-hydroxyhexobarbital by rat liver microsomes. Glucuronidation and dehydrogenation of 3'-hydroxyhexobarbital were also stereoselective and the S-configuration at the 3'-position was preferred. Alpha-3'-hydroxyhexobarbital from (-)-hexobarbital and the beta-isomer from (+)-hexobarbital were shown to be preferentially conjugated with glucuronic acid in rabbit urine, and to be preferentially dehydrogenated to form 3'-oxohexobarbital by rabbit and guinea pig 3-hydroxyhexobarbital dehydrogenases. A new metabolic pathway of hexobarbital was found in which 3'-oxohexobarbital reacts with glutathione to form 1,5-dimethylbarbituric acid and a cyclohexenone-glutathione adduct, a novel metabolite. 1,5-dimethylbarbituric acid was excreted into the urine and the cyclohexenone-glutathione adduct into the bile of rats dosed with hexobarbital. 3-hydroxyhexobarbital dehydrogenases that dehydrogenate 3-hydroxyhexobarbital into 3'-oxohexobarbital were purified from the liver cytosol of rabbits, guinea pigs, goats, rats, mice, hamsters, and humans and characterized. These enzymes were monomeric proteins and had molecular weights of about 34500-42000, and used NAD(+) and NADP(+) as cofactors, except for the human enzyme that had a molecular weight of about 58000 and used NAD(+) alone. Each enzyme exhibited its own characteristics. Substrate specificity demonstrated that 3-hydroxyhexobarbital dehydrogenases dehydrogenate not only alpha,beta-unsaturated cyclic and acyclic secondary alcohols but also some 17 beta-, 3 alpha-hydroxysteroids or both, except for the human enzyme. The amino acid sequence of the hamster enzyme indicated that it belongs to the aldo-keto reductase superfamily and hydroxysteroid dehydrogenase subfamily.

摘要

速可眠是一种短效催眠药,经细胞色素P450代谢为3'-羟基速可眠,然后由肝细胞质脱氢酶代谢为3'-氧代速可眠。已开发出通过薄层色谱法分离速可眠及其代谢物的新方法,并将其应用于研究速可眠对映体的代谢及速可眠的立体选择性代谢。大鼠肝微粒体优先将(+)-速可眠转化为β-3'-羟基速可眠,将(-)-对映体优先转化为α-3'-羟基速可眠。3'-羟基速可眠的葡萄糖醛酸化和脱氢反应也具有立体选择性,3'-位的S-构型更受青睐。来自(-)-速可眠的α-3'-羟基速可眠和来自(+)-速可眠的β-异构体在兔尿中优先与葡萄糖醛酸结合,并被兔和豚鼠的3-羟基速可眠脱氢酶优先脱氢形成3'-氧代速可眠。发现了速可眠的一条新代谢途径,即3'-氧代速可眠与谷胱甘肽反应形成1,5-二甲基巴比妥酸和一种环己烯酮-谷胱甘肽加合物,这是一种新的代谢物。1,5-二甲基巴比妥酸经尿液排出,环己烯酮-谷胱甘肽加合物经胆汁排出,这些均来自给予速可眠的大鼠。从兔、豚鼠、山羊、大鼠、小鼠、仓鼠和人的肝细胞质中纯化并鉴定了将3-羟基速可眠脱氢为3'-氧代速可眠的3-羟基速可眠脱氢酶。这些酶均为单体蛋白,分子量约为34500 - 42000,除分子量约为58000且仅使用NAD(+)的人源酶外,均以NAD(+)和NADP(+)作为辅因子。每种酶都有其自身特性。底物特异性表明,除人源酶外,3-羟基速可眠脱氢酶不仅能使α,β-不饱和环状和非环状仲醇脱氢,还能使一些17β-、3α-羟基类固醇脱氢或两者均脱氢。仓鼠酶的氨基酸序列表明它属于醛酮还原酶超家族和羟基类固醇脱氢酶亚家族。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验